The Effect of Dapagliflozin on Rate of Kidney Function Decline in Patients with CKD: A Prespecified Analysis from the DAPA-CKD Trial

被引：0
|
作者：
Heerspink, Hiddo J. L. [1 ,2 ]
Jongs, Niels [1 ]
Chertow, Glenn M. [3 ]
Langkilde, Anna Maria [4 ]
McMurray, John [5 ]
Correa-Rotter, Ricardo [6 ]
Rossing, Peter [7 ,8 ]
Sjostrom, David [4 ]
Stefansson, Bergur V. [4 ]
Toto, Robert D. [9 ]
Wheeler, David C. [10 ]
Greene, Tom [11 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[2] George Inst Global Hlth, Newtown, NSW, Australia
[3] Stanford Univ, Sch Med, Stanford, CA USA
[4] AstraZeneca, Gothenburg, Sweden
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico
[7] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[8] Univ Copenhagen, Copenhagen, Denmark
[9] UT Southwestern Med Ctr, Dallas, TX USA
[10] UCL, London, England
[11] Univ Utah Hlth, Salt Lake City, UT USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-OR51
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [31] Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial
    Zhang, Zhiyan
    Heerspink, Hiddo J. L.
    Chertow, Glenn M.
    Correa-Rotter, Ricardo
    Gasparrini, Antonio
    Jongs, Niels
    Langkilde, Anna Maria
    McMurray, John J., V
    Mistry, Malcolm N.
    Rossing, Peter
    Toto, Robert
    Vart, Priya
    Nitsch, Dorothea
    Wheeler, David C.
    Caplin, Ben
    LANCET PLANETARY HEALTH, 2024, 8 (04): : e225 - e233
  • [32] Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
    Heerspink, Hiddo J. L.
    Stefansson, Bergur, V
    Chertow, Glenn M.
    Correa-Rotter, Ricardo
    Greene, Tom
    Hou, Fan-Fan
    Lindberg, Magnus
    McMurray, John
    Rossing, Peter
    Toto, Roberto
    Langkilde, Anna Maria
    Wheeler, David C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (02) : 274 - 282
  • [33] THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH EGFR <30 ML/MIN/1.73M2: FINDINGS FROM THE DAPA-CKD TRIAL
    Chertow, G.
    Vart, P.
    Jongs, N.
    Toto, R.
    Gorriz, J. L.
    Hou, F. F.
    Mcmurray, J.
    Correa-Rotter, R.
    Rossing, P.
    Sjostrom, C. D.
    Stefansson, B. V.
    Langkilde, A. M.
    Wheeler, D. C.
    Heerspink, H. J. L.
    NEPHROLOGY, 2021, 26 : 33 - 34
  • [34] Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease A Health-Economic Analysis of DAPA-CKD
    McEwan, Phil
    Darlington, Oliver
    Miller, Ryan
    McMurray, John J. V.
    Wheeler, David. C. C.
    Heerspink, Hiddo J. L.
    Briggs, Andrew
    Bergenheim, Klas
    Sanchez, Juan Jose Garcia
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (12): : 1730 - 1741
  • [35] A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
    Heerspink, Hiddo J. L.
    Cherney, David
    Postmus, Douwe
    Stefansson, Bergur, V
    Chertow, Glenn M.
    Dwyer, Jamie P.
    Greene, Tom
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    McMurray, John J., V
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, C. David
    Toto, Robert D.
    Wheeler, David C.
    KIDNEY INTERNATIONAL, 2022, 101 (01) : 174 - 184
  • [36] EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ALBUMINURIA, WITH AND WITHOUT DIABETES, BY USE AND NON-USE OF CARDIOVASCULAR MEDICATIONS: DAPA-CKD TRIAL
    Correa-Rotter, Ricardo
    Chertow, Glenn
    Mark, Patrick
    Nowicki, Michal
    Vart, Priya
    Niels, Jongs
    Langkilde, Anna Maria
    Mcmurray, John
    Rossing, Peter
    Sjostrom, C. David
    Stefansson, Bergur
    Toto, Robert
    Wheeler, David
    Heerspink, Hiddo
    NEPHROLOGY, 2022, 27 : 31 - 31
  • [37] Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis
    McEwan, Phil
    Boyce, Rebecca
    Sanchez, Juan Jose Garcia
    Sjostrom, C. David
    Stefansson, Bergur
    Nolan, Stephen
    Correa-Rotter, Ricardo
    Rossing, Peter
    Chertow, Glenn M.
    McMurray, John J., V
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (05) : 1260 - 1270
  • [38] Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
    Rossing, Peter
    Inzucchi, Silvio E.
    Vart, Priya
    Jongs, Niels
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    DeMets, David L.
    Bengtsson, Olof
    Lindberg, Magnus
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Stefansson, Bergur, V
    Karlsson, Cecilia
    Chertow, Glenn M.
    Hou, Fan Fan
    Correa-Rotter, Ricardo
    Toto, Robert D.
    Wheeler, David C.
    McMurray, John J., V
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (01): : 24 - 34
  • [39] AMBIENT HEAT EXPOSURE AND ESTIMATED GLOMERULAR FILTRATION RATE TRAJECTORY: A POST-HOC ANALYSIS OF THE DAPA-CKD TRIAL
    Zhang, Zhiyan
    Ileerspink, Hiddo Lambers
    Chertow, Glenn
    Correa-Rotter, Ricardo
    Gasparrini, Antonio
    Jong, Niels
    Langkilde, Anna Maria
    Mistry, Malcolm
    Mcmurray, John
    Rossing, Peter
    Toto, Robert
    Vart, Priya
    Misch, Dorothea
    Wheeler, David C.
    Ben Caplin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I472 - I472
  • [40] Differences in Plasma Proteomic Profiles between Patients with and without Type 2 Diabetes and CKD: New insights from DAPA-CKD
    De la Rambelje, Mark Andre
    Jongs, Niels
    Greasley, Peter J.
    Agren, Rasmus
    Hammarstedt, Ann
    Sjostrom, David
    Voors, Adriaan A.
    Heerspink, Hiddo Jan L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345